New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
15:27 EDTSYKMariel Therapeutics to acquire Stryker's BMP-7 assets
Mariel Therapeutics announced that it has entered into a definitive agreement to acquire Stryker Corporation's Bone Morphogenetic Protein-7, or BMP-7, assets for the potential treatment of osteoarthritis, chronic kidney disease and other organ fibrosis conditions, lupus, and obesity. Under the terms of the agreement, Mariel acquired the rights to over 450 issued and pending patents, Stryker's BMP-7-related clinical and research data, and the associated biologic materials. Stryker will have a right of first negotiation for commercial rights in the area of osteoarthritis. Financial terms of the transaction were not disclosed.
News For SYK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
12:10 EDTSYKMOKO Social Media acquires 80% stake in Tagroom.com
Subscribe for More Information
October 20, 2014
07:12 EDTSYKCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
October 17, 2014
07:45 EDTSYKStryker price target lowered to $84 from $88 at Canaccord
Subscribe for More Information
October 16, 2014
16:04 EDTSYKStryker sees FY14 adjusted EPS at low end of $4.75-$4.80 guidance
Subscribe for More Information
16:02 EDTSYKStryker reports Q3 adjusted EPS $1.15, consensus $1.14
Reports Q3 revenue $2.39B, consensus $2.32B.
15:26 EDTSYKNotable companies reporting after market close
Subscribe for More Information
October 14, 2014
12:33 EDTSYKZimmer, Stryker have postive read-through from J&J, says Wells Fargo
Subscribe for More Information
11:11 EDTSYKJohnson & Johnson Ortho strength positive for Zimmer, says Piper Jaffray
Piper Jaffray said Johnson & Johnson's (JNJ) sequential Q3 strength in orthopedics, which included acceleration in both hips and knees, was surprising and a positive for Zimmer (ZMH). However, Piper expect sentiments on ortho names to remain muted until further into reporting season, noting that Stryker (SYK) is scheduled to report Thursday after the close. The firm has Neutral rating on Johnson & Johnson and Stryker and an Overweight rating on Zimmer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use